Determination of acquisition frequency for intrafractional motion of pancreas in CyberKnife radiotherapy.(2014)

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.(2019)

Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity.(2013)

Comparative research on the efficacy of CyberKnife® and surgical excision for Stage I hepatocellular carcinoma.(2013)

Stereotactic body radiation therapy using the CyberKnife® system for patients with liver metastases.(2014)

Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy.(2016)

Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.(2019)

Long-term survival in patients treated with a robotic radiosurgical device for liver metastases.(2019)

Gated volumetric-modulated arc therapy vs. tumor-tracking CyberKnife radiotherapy as stereotactic body radiotherapy for hepatocellular carcinoma: A dosimetric comparison study focused on the impact of respiratory motion managements.(2016)